Christopher D. Turner's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 303,105 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 303,105 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 144,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 107,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 47,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 41,100 | 0 | - | - | Class A Common Stock - Restricted Stock Units | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 37,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | 15 Jul 2026 | 31,530 | 0 | - | - | Class A Common Stock | ||
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 17,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 14,350 | - | 0 | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 0 | - | - | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 2,835 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 72,630 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 97.96 per share. | 05 Jan 2026 | 1,929 | 58,628 | - | 98.0 | 188,965 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 97.33 per share. | 05 Jan 2026 | 1,635 | 55,355 | - | 97.3 | 159,135 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 96.75 per share. | 05 Jan 2026 | 1,321 | 56,990 | - | 96.8 | 127,807 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 96.85 per share. | 05 Jan 2026 | 1,119 | 60,557 | - | 96.8 | 108,375 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 05 Jan 2026 | 871 | 61,676 | - | 96.1 | 83,668 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 05 Jan 2026 | 317 | 58,311 | - | 98.5 | 31,231 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 05 Jan 2026 | 225 | 55,130 | - | 98.4 | 22,140 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 18,750 | 66,563 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 06 Jan 2025 | 2,173 | 62,547 | - | 80.5 | 175,013 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 78.28 per share. | 06 Jan 2025 | 1,152 | 65,411 | - | 78.3 | 90,179 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 06 Jan 2025 | 691 | 64,720 | - | 79.3 | 54,817 | Class A Common Stock |
| Nuvalent Inc (Class A) | Turner D. Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | D. Turner Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 33,300 | 47,813 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2023 | 2,665 | 311,100 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 48.93 per share. | 26 Jul 2023 | 2,665 | 14,513 | - | 48.9 | 130,398 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 26 Jul 2023 | 2,665 | 17,178 | - | 6.9 | 18,362 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.85 per share. | 26 Jul 2023 | 2,365 | 14,513 | - | 46.8 | 110,800 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2023 | 2,365 | 313,765 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 26 Jul 2023 | 2,365 | 16,878 | - | 6.9 | 16,295 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2023 | 200 | 316,130 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.82 per share. | 20 Jul 2023 | 200 | 14,513 | - | 46.8 | 9,364 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 20 Jul 2023 | 200 | 14,713 | - | 6.9 | 1,378 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 46.80 per share. | 20 Jul 2023 | 100 | 14,513 | - | 46.8 | 4,680 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2023 | 100 | 316,330 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 20 Jul 2023 | 100 | 14,613 | - | 6.9 | 689 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 05 Jun 2023 | 10,235 | 24,748 | - | 6.9 | 70,519 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.86 per share. | 05 Jun 2023 | 10,235 | 14,513 | - | 44.9 | 459,142 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 10,235 | 316,430 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 144,200 | 144,200 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 May 2022 | 14,513 | 14,513 | - | 6.9 | 99,995 | Class A Common Stock |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 14,513 | 326,665 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Christopher D. Turner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 107,000 | 107,000 | - | - | Stock Option (Right to Buy) |